Work

SR141716, a central cannabinoid (CB1) receptor antagonist, blocks the motivational and dopamine-releasing effects of nicotine in rats

Year: 2002

Type: article

Source: Behavioural Pharmacology

DOI: 10.1097/00008877-200209000-00018

Authors: C. Cohen, G. Perrault, C. Voltz, R. Steinberg, P. Soubrié

Institutions: Sanofi (France), Sanofi (Turkey)

Language: English

Topic: Cannabis and Cannabinoid Research

Subfield: Pharmacology (medical)

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2001109168

FWCI: 14.03

Cites: 77

Cited by: 405

Related to: 10